MEDINTEL

Medical testing services; medical testing services for detection, diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, namely, third-party testing of patient urine, blood, and/or oral fluids, and skin or wound specimens; medical services, namely, medication monitoring and drug detection services to evaluate patient treatment plans to improve clinical outcomes and patient safety; drug use testing services, namely, testing patient urine, blood and/or oral fluid for medication or drug abuse and/or compliance with patient prescriptions; medical pharmacogenetic testing services for detection or treatment purposes that predict how a patient's genetic makeup may impact the patient's response to specific medications; medical testing services for detection of infectious disease; medical testing services for identification of appropriate antimicrobial therapy to improve clinical outcomes